Compass Therapeutics (CMPX) Tax Provisions (2019 - 2021)

Compass Therapeutics has reported Tax Provisions for 3 years, with the latest figure at -$13000.0 in Q4 2021.

• Quarterly Tax Provisions changed N/A year-over-year to -$13000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was -$13000.0 (down 120.31% YoY) and the FY2020 annual result came in at $32000.0, down 64.84% from the prior year.
• Tax Provisions retreated to -$13000.0 in Q4 2021 per CMPX's latest filing, from $32000.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $81000.0 in Q3 2019 and troughed at -$13000.0 in Q4 2021.
• A 3-year average of $33833.3 and a median of $32000.0 in 2020 frame the typical range for Tax Provisions.
• The widest YoY moves for Tax Provisions: up 41.82% in 2020, down 60.49% in 2020.
• Over 3 years, Tax Provisions stood at $81000.0 in 2019, then plunged by 60.49% to $32000.0 in 2020, then tumbled by 140.62% to -$13000.0 in 2021.
• According to Business Quant data, Tax Provisions over the past three periods registered -$13000.0, $32000.0, and $32000.0 for Q4 2021, Q3 2020, and Q2 2020 respectively.